Tae Yang Kim Selected Research

Arthrogryposis renal dysfunction cholestasis syndrome

4/2021

Immune Modulatory Activities of Arginyl-Fructose (AF) and AF-Enriched Natural Products in In-Vitro and In-Vivo Animal Models.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tae Yang Kim Research Topics

Disease

1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022
1	Arthrogryposis renal dysfunction cholestasis syndrome 04/2021
1	Body Weight (Weight, Body) 01/2021
1	Type 2 Diabetes Mellitus (MODY) 01/2021
1	Obesity 01/2021
1	Weight Gain 01/2021
1	Weight Loss (Weight Reduction) 01/2021
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2021
1	Hyperglycemia 01/2020
1	Acne Vulgaris 06/2019
1	Hypertension (High Blood Pressure) 01/2019
1	Neoplasms (Cancer) 01/2019
1	Chondrosarcoma 10/2018
1	Osteoarthritis 10/2018
1	Aneurysm (Aneurysms) 01/2015

Drug/Important Bio-Agent (IBA)

2	LipidsIBA 01/2021 - 06/2019
1	MesothelinIBA 01/2022
1	Chimeric Antigen ReceptorsIBA 01/2022
1	fructosyl arginineIBA 04/2021
1	Alanine Transaminase (SGPT)IBA 01/2021
1	GO2KA1IBA 01/2021
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2021
1	OligosaccharidesIBA 01/2021
1	ChitosanIBA 01/2021
1	AdiponectinIBA 01/2021
1	Sucrase (Sucrose alpha-D-Glucohydrolase)IBA 01/2020
1	chrysophanic acidIBA 06/2019
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2019
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2019
1	EnzymesIBA 01/2019
1	NADP (NADPH)IBA 01/2019
1	Superoxides (Superoxide)IBA 01/2019
1	Biological ProductsIBA 01/2019
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2019
1	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2019
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 01/2019
1	Messenger RNA (mRNA)IBA 01/2019
1	Angiotensin IIIBA 01/2019
1	AntioxidantsIBA 01/2019
1	ecliptasaponin AIBA 10/2018
1	PolymersIBA 01/2015

Therapy/Procedure

1	Glycemic Control 01/2021
1	Oral Administration 01/2021